Key result
Natriuretic peptides accurately and cost-effectively diagnose acute heart failure in the ER despite patient variables.
Why the study?
Does the measurement of natriuretic peptides improve the diagnostic accuracy of acute heart failure and cost-effectiveness in patients presenting with dyspnea in the emergency room?
Does the measurement of natriuretic peptides improve the diagnostic accuracy of acute heart failure and cost-effectiveness in patients presenting with dyspnea in the emergency room?
Natriuretic peptides are a cost-effective and highly accurate tool for diagnosing acute heart failure in the emergency room, with age-stratified cutoffs and machine learning models helping to overcome confounding factors.
Supports natriuretic peptide testing for ER dyspnea; leaves open refined thresholds for age, renal function, and obesity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Humberto Villacorta (2024) conducted a review in Acute heart failure in patients with dyspnea. Natriuretic peptides (BNP and NT-proBNP) vs. Clinical examination alone was evaluated. Natriuretic peptides are highly accurate and cost-effective for diagnosing acute heart failure in emergency room patients with dyspnea, though accuracy is influenced by age, renal function, and obesity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: